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Figure 1. Bryophytes and other herbs on sale in a Yunnan, China, market. Rhodobryum giganteum (upper bag) and Leucobryum
(lower bag), both called Hui Xin Cao. Photo by courtesy of Eric Harris.

Antibiotics and Other Biologically Active Substances
Bryophyte species actually produce broad-range
antibiotics (Asakawa 2007a, b, 2008; Asakawa et al. 2013).
Their usage in surgical dressings, diapers, and other human
medicinal applications is well known. And their use has
not been confined to Asia (Frahm 2004), but is known in
Brazil (Pinheiro da Silva et al. 1989), England (Wren
1956), North America (Pejin et al. 2011a, b), and Germany

(Frahm 2004), as well as in China (Ding 1982; Wu 1982)
and India (Watts 1891). Frahm (2007) has reviewed the
literature on bryophytes and their antibiotic activity.
Bryophytes discourage the feeding by a variety of
organisms, as discussed in the chapters on terrestrial
insects, arthropods, and other interaction chapters. Frahm
and Kirchhoff (2002) showed that extracts of the epiphytic
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moss Neckera crispa (Figure 2) and leafy liverwort Porella
obtusata (Figure 3) both discouraged feeding by the
Portuguese slug Arion lusitanicus (Figure 4).
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skeletal acetogenins, phenolic compounds, and terpenoids
were identified. Testing of these compounds has led to the
commercial development of a natural pesticide (Frahm
2004).
Leptolejeunea (Figure 5) and Moerckia (Figure 6) are
distinctly aromatic (Schuster 1966), Lophozia bicrenata
(Figure 7) has a pleasant odor, species of Solenostoma
(Figure 8) smell like carrots, Geocalyx graveolens (Figure
9) has a turpentine-like odor, and Conocephalum conicum
(Figure 10) smells like mushrooms.
The tropical
Plagiochila rutilans (Figure 11) smells like peppermint,
caused by several menthane monoterpenoids (Heinrichs et
al. 2001).

Figure 2. Neckera crispa, a species that discourages the
Portuguese slug from eating it. Photo by Jan-Peter Frahm, with
permission.

Figure 5. Leptolejeunea elliptica, a species with a distinct
odor. Photo by Yan Jia-dang, through Creative Commons.

Figure 3. Porella obtusata, a species that discourages the
Portuguese slug from eating it. Photo by Michael Lüth, with
permission.

Figure 6. Moerckia flotoviana female, a species with a
distinct odor. Photo by Michael Lüth, with permission.

Figure 4. Arion lusitanicus, a slug that avoids eating
extracts of the moss Neckera crispa and leafy liverwort Porella
obtusata. Photo by Ondřej Zicha, through Creative Commons.

One indication of the presence of unique and
potentially important pharmaceutically and anti-feedant
chemicals in bryophytes is the presence of unique odors.
This is especially true for liverworts, with more than
several hundred new compounds identified among them
(Asakawa 2012). In addition, more than 40 new carbon

Figure 7. The leafy liverwort Lophozia bicrenata. Photo by
Michael Lüth.
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Figure 8. Solenostoma hyalina, a species that smells like
carrots. Photo by Janice Glime.

Figure 11. Plagiochila sp. Plagiochila rutilans smells like
peppermint. Photo by Lin Kyan, with permission.

It appears that these unique odors result from a
combination of many compounds, including monoterpene
hydrocarbons such as α-pinene, ß-pinene, camphene,
sabinene, myrcene, alpha-terpinene, limonene, fatty acids,
and methyl esters of low molecular weight (Hayashi et al.
1977). For example, Isotachis japonica (Figure 12) has at
least three aromatic esters:
benzyl benzoate, benzyl
cinnamate, and B-phenylethyl cinnamate (Matsuo et al.
1971).

Figure 9.
The leafy liverwort Geocalyx graveolens.
Underleaf is indicated by the red star. Photo by Michael Lüth.

Figure 12. Isotachis sp. Isotachis japonica has at least three
aromatic esters. Photo by George Shepherd, through Creative
Commons.

Figure 10. Conocephalum conicum, a species that smells
like mushrooms. Photo by Hermann Schachner, through Creative
Commons.

But can you imagine using mosses to lower your
cholesterol? Yes, mosses contain polyunsaturated fatty
acids that are already known to have important potentials in
human medicine, such as preventing atherosclerosis and
cardiovascular
disease,
reducing
collagen-induced
thrombocyte aggregation, and lowering triacylglycerols and
cholesterol in plasma (Radwan 1991).

But progress in purifying and identifying bryophyte
biochemical components and demonstrating their antibiotic
effects has been slow. As early as 1952, Madsen and Pates
found inhibition of microorganisms in products of
bryophytes, including Sphagnum portoricense (Figure 13),
S. strictum (Figure 14), Conocephalum conicum (Figure
10), and Dumortiera hirsuta (Figure 15) (see also
Sabovljević et al. 2011; Chandra et al. 2017). Pavletic and
Stilinovic (1963) found that Dicranum scoparium (Figure
16) strongly inhibited all bacteria tested but Gram-negative
Escherichia coli (Figure 17). McCleary and Walkington
(1966) considered that non-ionized organic acids and
polyphenolic compounds might contribute to the antibiotic
properties of bryophytes and found eighteen mosses that
strongly inhibited one or both of Gram-positive and Gramnegative bacteria, the most active being Atrichum (Figure
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20), Dicranum (Figure 16), Mnium (Figure 18),
Polytrichum (Figure 19), and Sphagnum. Reminiscent of
Dicranum scoparium (Figure 16), Atrichum undulatum
(Figure 20) was effective on everything tested except
Enterobacter aerogenes (drug resistant and infectious to
people with weak immune systems; Figure 21) and E. coli.

Figure 16. Dicranum scoparium, a species that inhibited all
bacteria tested but Gram-negative Escherichia coli. Photo by
Janice Glime.

Figure 13. Sphagnum portoricense, a species that inhibits
microorganisms. Photo by Blanka Shaw, with permission.

Figure 17. Escherichia coli, a species that is inhibited by
acetone-soluble extracts of several thallose liverwort species.
Photo by NIAID, through Creative Commons.
Figure 14. Sphagnum strictum, a species that inhibits
microorganisms. Photo by Jan-Peter Frahm, with permission.

Figure 15. Dumortiera hirsuta, a species that inhibits
microorganisms. Photo by Michael Lüth, with permission.

Figure 18. Mnium spinulosum. Members of the genus
Mnium are among the most active against one or both of Grampositive and Gram-negative bacteria. Photo by Michael Lüth,
with permission.
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bibenzyls could inhibit growth of Staphylococcus aureus
(Figure 25) at concentrations of 20.3 µg ml-1. Out of more
than 80 species tested, Ichikawa (1982) and coworkers
(1983) found antimicrobial activity in nearly all. Acyclic
acetylenic fatty acid and cyclophentenonyl fatty acid
extracts from the mosses completely inhibited the growth
of the rice blast fungus Magnaporthe grisea (Figure 26).
Belcik and Wiegner (1980) reported antimicrobial activity
in extracts of the liverworts Pallavicinia (Figure 27) and
Reboulia (Figure 28), and Isoe (1983) reported it from
Porella (Figure 29).

Figure 19. Polytrichum commune. Members of the genus
Polytrichum are among the most active against one or both of
Gram-positive and Gram-negative bacteria. Photo by Michael
Lüth, with permission.

Figure 22. Barbula convoluta, member of a genus with high
antibacterial activity. Photo by Michael Lüth, with permission.

Figure 20. Atrichum undulatum is a moss that is very
effective against a wide range of bacteria. Photo by Michael
Lüth.

Figure 23. Timmiella sp., a genus with high antibacterial
activity. Photo by Ken-ichi Ueda through Creative Commons.

Figure 21. Enterobacter aerogenes, a bacterium that seems
to be resistant to extracts of 18 moss species that negatively affect
other bacteria. Photo by Alexa Rakusin Muna, through Creative
Commons.

Gupta and Singh (1971) found high occurrence of
antibacterial activity in extracts of Barbula species (Figure
22), reaching as high as 36.2%, whereas it was only half
that in Timmiella species (Figure 23) (18.8%). In 1982,
Asakawa et al. (1982) isolated three prenyl bibenzyls from
Radula spp. (Figure 24) and demonstrated that these

Figure 24. Radula complanata, a species with bibenzyls that
could inhibit growth of Staphylococcus aureus. Photo by Michael
Lüth, with permission.
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Figure 28. Reboulia hemisphaerica, member of a genus
with reported antimicrobial activity. Photo by Malcolm Storey
<www.discoverlife.org>, with online permission.

Figure 25. Staphylococcus aureus, a bacterium that is not
inhibited by the thallose liverwort Riccia fluitans. Photo by
NIAID, through Creative Commons.

Figure 29. Porella platyphylla, member of a genus with
reported antimicrobial activity. Photo by Tim Waters through
Creative Commons.

Figure 26. Magnaporthe grisea, a plant pest that is inhibited
by several liverworts. Photo by IRRI Photos, through Creative
Commons.

Figure 27. Pallavicinia lyellii, member of a genus with
reported antimicrobial activity. Photo by Jan-Peter Frahm, with
permission.

Another three species of mosses [Anomodon rostratus
(Figure 30), Plagiomnium cuspidatum (Figure 31),
Orthotrichum rupestre (Figure 32)] produce substances
that inhibit bacteria and fungi, but these inhibitors seem to
be unstable products that vary considerably among species
and possibly also among seasons (McCleary et al. 1960).
Indeed, it would appear that some of these antibiotic
compounds are the very ones that bryophytes produce in
response to stress. However useful they may be, it seems
that these discoveries have not yet found their way into
medical practice.

Figure 30. Anomodon rostratus, a species that inhibits
bacteria and fungi. Photo by Dale A. Zimmerman Herbarium,
Western New Mexico University, with permission.
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On the other hand, some researchers claim that
antibiotic properties of some mosses, including Sphagnum
(Figure 13, Figure 14), may actually be the work of
associated microorganisms.
In some cases, e.g.
Sphagnum, it may be Penicillium sp. (Figure 34) effecting
this antibiotic ability (Lewington 1990). Or is it the closely
associated Cyanobacteria, such as Nostoc (Figure 35)
(Spjut et al. 1988; Solheim & Zielke 2002)?

Figure 31. Plagiomnium cuspidatum, a species that inhibits
bacteria and fungi. Photo by Štĕpán Koval, with permission.

Figure 34. Penicillium expansum on pear, in a genus that
can grow on Sphagnum and may contribute to its antibiotic
effects. Photo by H. J. Larsen, through Creative Commons.

Figure 32. Orthotrichum rupestre, a species that inhibits
bacteria and fungi. Photo by Michael Lüth, with permission.

Scientists have found innumerable kinds of biological
activity in compounds from bryophytes. Even in a single
species, one might find multiple kinds of activity. For
example, the liverworts Plagiochasma japonica and
Marchantia emarginata subsp. tosana (Figure 33) exhibit
antitumor activity, antifungal and antimicrobial activity,
inhibition of superoxide release, inhibition of thrombin
activity, and muscle relaxation (Lahlou et al. 2000). As is
often the case with herbal medicine, the effect of the total
extract is better than that of the isolated compounds,
perhaps due to a synergistic effect (Frahm 2004).

Figure 33. Marchantia emarginata subsp. tosana, a
subspecies with a wide range of medicinal properties. Photo by
Taiwan Mosses, through Creative Commons.

Figure 35. Nostoc pruniforme, in a genus with close
associations with Sphagnum and other bryophytes and could
contribute to antibiotic properties. Photo by Lairich Rig, through
Creative Commons.

Painter (2003) notes that Sphagnum (Figure 13, Figure
14) can be 3-4 times as absorbent as cotton equivalents.
But its call to fame seems to be its ability to react
chemically with all sorts of proteins. Sphagnum species
have the potential to immobilize whole bacterial cells,
enzymes, exotoxins, and lysins that are secreted by most of
the invasive pathogens. Once these are immobilized, they
are inactivated by a Maillard reaction.
The Maillard reaction makes this story complex. It is
known to suppress the virulence gene expression operon in
the bacterium Listeria monocytogenes (Figure 36) (SheikhZeinoddin et al. 2000), so that is a good thing. On the
other hand, a variety of foods form potential cancer-causing
acrylamides, especially fried foods (Stadler et al. 2002).
Such acrylamides can be released by thermally treating
certain amino acids such as asparagine, especially in
combination with reducing sugars through the Maillard
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reaction. The early Maillard reaction products are Nglycosides. Painter (1998) found that the Maillard reaction
inhibits microbial growth in animal products preserved in
bogs by sequestering ammonia, amino acids, and peptides,
whereas the polymeric end-products (melanoidins) inhibit
their growth by cross-linking the polypeptide chains and
sequestering essential multivalent metal cations. In short,
the Maillard reaction appears to be an important component
of the Sphagnum (Figure 13, Figure 14) antibiotic activity.
Furthermore, its preservative ability correlates with α-ketocarboxylate groups in a glycuronoglycan (sphagnan) that
comprises ∼60% of the holocellulose in the Sphagnum
hyaline cell walls.
Figure 38.
Spodoptera littoralis, a species that is
discouraged from eating the liverwort Riccardia polyclada by its
chemical compounds. Photo from Forestry Images, through
Creative Commons.

Figure 36. Listeria monocytogenes, a bacteria species that is
inhibited by extracts of the leafy liverwort Porella cordaeana.
Photo from CDC, through public domain.

Harris (2009) considered phylogenetic, elevational,
and latitudinal relationships of the production of flavonoids
in medicinal mosses. He was unable to show any
significant correlation between phylogenetic independent
contrasts of total phenolic content, number of flavonoids,
or percent luteolin derivatives. He furthermore found no
correlation with elevation or latitude. He could not rule out
the possible correlation with fine-scale ecological features,
and he considered flavonoid variation to reflect recent
evolution.
Labbé et al. (2007) tested the thallose liverwort
Riccardia polyclada for potential pesticidal properties.
They identified four compounds that contributed to
lethality in the brine shrimp (Artemia salina; Figure 37).
Two of the compounds had moderate activity as an
antifeedant for the African cotton leafworm (Spodoptera
littoralis; Figure 38). They also inhibited culture growth of
the fungal plant pathogen Cladosporium herbarum (Figure
39).

Figure 37. Artemia salina, a species that is killed by extracts
from the liverwort Riccardia polyclada.
Photo by Hans
Hillewaert, through Creative Commons.

Figure 39. Cladosporium spp., fungal pathogens that are
inhibited by extracts from the liverwort Riccardia polyclada.
Photo from Mold Treatment Centers of America, through Creative
Commons.

Antimicrobial Activity
Our knowledge of antimicrobial activity of bryophytes
is mostly based on Sphagnum (Figure 13, Figure 14).
However other bryophytes are now known to have
antibiotic properties. Some of these may just be folklore as
they have not been tested experimentally. For example,
Cheng et al. (2008) reported the folk use of Polytrichum to
treat pneumonia.
And we have already seen that
Polytrichum commune (Figure 19) is used in a tea for
treating colds (Gulabani 1974; Beike et al. 2010).
Nevertheless, antibiotic properties have been
demonstrated in the laboratory. Moss activity against
Gram-positive and Gram-negative bacteria have been
demonstrated (Basile et al. 1999; Merkuria et al. 2005; Zhu
et al. 2006). Asakawa (2007a, b) has demonstrated many
effects of liverworts.
Kumar et al. (2007), in their review of classical
ethnobotanical Indian uses, reported the antibacterial value
of the mosses Anomodon rostratus (Figure 30), Atrichum
angustatum (Figure 40), A. undulatum (Figure 41), and
Hyophila involuta (Figure 42) and the thallose liverworts
Conocephalum conicum (Figure 10) and Dumortiera
hirsuta (Figure 15). These bryophytes reportedly produce
antibiotics. The leafy liverwort Radula complanata
(Figure 24) similarly has antimicrobial properties. To these
we can add the antiseptic properties of Frullania tamarisci
(Figure 43) (Asakawa 2007b; Chandra et al. 2017) and
antimicrobial activity of Pallavicinia sp. (Figure 27)
(Azuelo et al. 2011; Chandra et al. 2017).
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Figure 40.
Atrichum angustatum, a species with
antibacterial properties. Photo by Janice Glime.

Figure 41.
Atrichum undulatum, a species with
antibacterial properties.
Photo by Brian Eversham, with
permission.

Figure 42. Hyophila involuta, a species with antibacterial
properties. Photo by Michael Lüth, with permission.

Figure 43. Frullania tamarisci, an epiphytic species with
antiseptic properties, having both allergenic and medicinal
properties. Photo by Michael Lüth, with permission.

Recent tests on the floating thallose liverwort Riccia
fluitans (Figure 44) from Florida indicated no ability to
inhibit growth of the tested bacteria [Pseudomonas
aeruginosa (Figure 45), Staphylococcus aureus (Figure
25)] or yeast (Candida albicans; Figure 46) (Pates &
Madsen 1955). Vashistha et al. (2007) determined the
antimicrobial activity of three other thallose liverworts.
They found that water soluble extracts from
Conocephalum conicum (Figure 10), Marchantia
polymorpha
(Figure
47),
and
Plagiochasma
appendiculatum (Figure 48) had no effect on any of the
pathogens tested [Gram-negative bacteria Escherichia coli
(Figure 17) and Salmonella typhi (a variant of S. enterica;
Figure 49)] and fungi Aspergillus niger (Figure 50) and
yeast Candida albicans (Figure 46). However, acetonesoluble extracts of all three bryophyte species were
inhibitory against the pathogens. They were more effective
against the growth of S. typhi than against E. coli.
Plagiochasma appendiculatum had a strong inhibitory
effect against A. niger and Conocephalum conicum was
strongly inhibitory to Candida albicans.

Figure 44. Riccia fluitans, a species that was unable to
inhibit the growth of several tested bacteria. Photo by Štĕpán
Koval, with permission.
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Figure 45. Pseudomonas aeruginosa, a species that is not
inhibited by Riccia fluitans. Photo by Janice Haney Carr,
through Creative Commons.

Figure 46. Candida albicans, a yeast species that is inhibited
by extracts of the liverworts Conocephalum conicum,
Marchantia polymorpha, and Plagiochasma appendiculatum,
but not Riccia fluitans. Photo from Public Health Image Library,
through public domain.
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Figure 48. Plagiochasma appendiculatum, a species that is
effective against some pathogens. Photo by Ying Jia-dong,
through Creative Commons.

Figure 49. Salmonella enterica invading human cells.
Photo by NIAID, through public domain.

Figure 50. Aspergillus niger, a fungal species that is
inhibited by extracts of the liverworts Conocephalum conicum,
Marchantia polymorpha, and Plagiochasma appendiculatum.
Photo from Public Health Image Library, through public domain.

Figure 47. Marchantia polymorpha subsp. ruderalis. This
species had no effect on the fungi or Gram negative bacteria
tested by Vashistha et al. Photo by Malcolm Storey, through
Creative Commons

Bukvicki et al. (2012), using solid-phase
microextraction-gas chromatography mass spectrometry,
explored the volatile components of the leafy liverwort
Porella cordaeana (Figure 51). Using methanol, ethanol,
and ethyl acetate to extract terpenoids, they were able to
identify sesquiterpene hydrocarbons and monoterpene
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hydrocarbons. These same hydrocarbons were active
against the eleven food microorganisms tested, but at
different concentrations among the microorganisms. The
fungi among these will be discussed blow. Affected
bacterial strains were Salmonella enteritidis (food
poisoning that causes diarrhea, fever, and abdominal
cramps; Figure 52), Escherichia coli (commonly found in
lower intestine of warm-blooded organisms with some
strains causing food poisoning; Figure 17), and Listeria
monocytogenes (very virulent food pathogen that causes the
infection listeriosis; Figure 36). Methanol extracts showed
the best activity.
Figure 53. SEM of Bacillus subtilis, a species that is
inhibited by extracts of several bryophyte species. Photo by
Davehwng, through Creative Commons.

Figure 51. Porella cordaeana, a species that is able to
inhibit a variety of yeasts and bacteria. Photo by J. C. Schou, with
permission.
Figure 54. Micrococcus luteus, a bacteria species that is
inhibited by extracts of several bryophyte species. Photo by
Janice Carr, through public domain.

Basile et al. (1999) isolated seven pure flavonoids
from five species of mosses. Some of these exhibited
strong antibacterial effects against the bacteria
Enterobacter cloaceae (Figure 55), E. aerogenes (Figure
56), and Pseudomonas aeruginosa (Figure 45). They were
mainly active against Gram-negative bacteria that caused
severe opportunistic infections and were at the same time
resistant to commonly used antibacterial therapy. This
means that the bryophyte products could become important
tools in treating some bacterial infections.

Figure 52. Salmonella enteritidis, a bacteria species that is
inhibited by extracts of Porella cordaeana. Photo through OGL
(public domain).

It appears that differences in bryophyte extract activity
among various pathogens may be common. Extracts of the
liverworts Marchantia polymorpha (Figure 47), Porella
platyphylla (Figure 29), and the moss Dicranum
scoparium (Figure 16) showed antimicrobial effects on the
Gram-positive bacteria Bacillus subtilis (Figure 53),
Staphylococcus aureus (Figure 25), and Micrococcus luteus
(Figure 54) (Pavletic & Stilinovic 1963; Frahm 2004).
These same bryophytes exhibited no activity against Gramnegative Escherichia coli (Figure 17).

Figure 55. Enterobacter cloaceae, a species that is active
against Gram-negative bacteria. Photo by Nathan Reading,
through Creative Commons.
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Figure 56. Enterobacter aerogenes, a species that is active
against Gram-negative bacteria. Photo by Riraq25, through
Creative Commons.

Ariyo et al. (2011) compared the efficacy of extracts
from the Nigerian thallose liverwort Riccia nigerica as
antimicrobial agents. These extracts were tested against the
bacteria Bacillus subtilis (Figure 53), Pseudomonas
aeruginosa (Figure 45), Shigella dysenteriae (Figure 57),
and Staphylococcus aureus (Figure 25) and fungi Rhizopus
spp. (Figure 58), Aspergillus flavus (Figure 59), A. niger
(Figure 50), Penicillium spp. (Figure 34), and and
demonstrated strong significant antibacterial and antifungal
activity.

Figure 59. Aspergillus flavus, a fungal species that is
inhibited by extracts of Riccia nigerica. Photo by Medmyco,
through Creative Commons.

The leafy liverwort Ptilidium pulcherrimum (Figure
60) exhibits antimocrobial activity against both Gram +
bacteria and Gram negative bacteria, but the effect is
greater on the Gram positive bacteria (Veljić et al. 2010).

Figure 57. Shigella dysenteriae, a bacterial species that is
inhibited by extracts of Riccia nigerica. Photo by Public Health
Image Library, through public domain.
Figure 60. Ptilidium pulcherrimum, a species that is
effective against both Gram positive and Gram negative bacteria.
Photo by Hermann Schachner, through Creative Commons

Antifungal Activity

Figure 58. Rhizopus on yam, a fungal species that is
inhibited by extracts of Riccia nigerica. Photo by Charles
Averre, through Creative Commons.

Although mosses are known to harbor fungi and will
quickly become infected if kept moist in a plastic bag,
some fungi are inhibited by many species of bryophytes,
including many that cause skin infections. Jennings (1926)
reported moss immunity to molds as early as 1926, but the
possibility of using them as a source of antifungal activity
seems to have been largely overlooked. Among these, the
cosmopolitan moss Hypnum cupressiforme (Figure 61)
has remarkable antibacterial and antifungal effects. Ven
Hoof et al. (1981) demonstrated strong antibacterial and
antifungal effects by extracts of Hypnum cupressiforme.
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Figure 61. Hypnum cupressiforme, a species that is
effective against fungi that cause skin infections. Photo by
Michael Lüth.

Kumar et al. (2007) report antifungal properties for the
widespread leafy liverwort Porella platyphylla (Figure 29).
Ando and Matsuo (1984) demonstrated antifungal effects
of bryophytes on human pathogenic fungi, but they warned
that while the bryophyte extracts have fungicidal and
antifeedant effects, they also may cause allergic reactions
and dermatitis for some humans.
Bukvicki et al. (2012), using solid-phase
microextraction-gas chromatography mass spectrometry,
explored the volatile components of the related liverwort
Porella cordaeana (Figure 51). Using methanol, ethanol,
and ethyl acetate to extract terpenoids, they were able to
identify sesquiterpene hydrocarbons and monoterpene
hydrocarbons. These same hydrocarbons were active
against the eleven food microorganisms tested, but at
different concentrations among the microorganisms. These
included the yeasts Saccharomyces cerevisiae (yeast used
in wine making, baking, and brewing, but antibodies
against S. cerevisiae are found in 60-70% of patients with
Crohn's disease; Figure 62), Zygosaccharomyces bailii
(species causing significant spoilage in the food industry;
Figure 63), Aureobasidium pullulans (an inhabitant
of humidifiers or air conditioners that can lead to
hypersensitivity pneumonitis;
Figure
64),
Pichia
membranifaciens (species causing grey mold of fruits;
Figure 65) (2 strains), Pichia anomala (used in
winemaking) (2 strains), and Yarrowia lipolytica (used in
industrial microbiology for production of specialty lipids).
Methanol extracts showed the best activity.

Figure 63. Zygosaccharomyces bailii, a yeast species that is
inhibited by extracts of Porella cordaeana. Photo by DTDT,
through Creative Commons.

Figure 64. Aureobasidium pullulans, a yeast species that is
inhibited by extracts of the leafy liverwort Porella cordaeana.
Photo by Tom Volk, through Creative Commons.

Figure 65. Pichia membranaefaciens, a yeast species that is
inhibited by extracts of Porella cordaeana. Photo by Luciana
Francisco Fleuri & Hélia Harumi Sato, through Creative
Commons.

Figure 62. Saccharomyces cerevisiae SEM, a yeast species
that is inhibited by extracts of the leafy liverwort Porella
cordaeana. Photo by Mogana Das Murtey and Patchamuthu
Ramasamy, through Creative Commons.

The leafy liverwort Ptilidium pulcherrimum (Figure
60) is not only effective against bacteria, but also against
fungi (Veljić et al. 2010). Its best antifungal activity was
against Trichoderma viride (Figure 66), compared to the
activity of the synthetic bifonazol.
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Figure 66. Trichoderma viride conidiophores, a fungal
species that is inhibited by Atrichum undulatum, Physcomitrella
patens, and Marchantia polymorpha. Photo by Ninjatacoshell,
through Creative Commons.

The absence of fungal diseases in liverworts led Pryce
(1972) to suggest that lunularic acid, a hormone that
affects aging in liverworts but not in mosses, might be
responsible for liverwort antifungal activity. Banerjee and
Sen (1979; Bannerjee 1974) found that the degree of
antibiotic activity in a given species may depend on the age
of the gametophyte; Matsuo et al. (1982a, 1982b, 1983)
supported this conclusion by demonstrating that antifungal
activity against Botrytis cinerea (Figure 67), Pythium
debaryanum (Figure 68), and Rhizoctonia solani (Figure
69) by the liverwort Herbertus aduncus (Figure 70) was
age-dependent. They subsequently isolated three aging
substances from it:
(-)-alpha-herbertenol; (-)-Betaherbertenol, and (-)-alpha-formylherbertenol.
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Figure 68. Pythium sp. The liverwort Herbertus aduncus
can exercise antifungal activity against this fungus, but activity is
age-dependent. Photo by Josef Reischig, through Creative
Commons.

Figure 69. Rhizoctonia solani infecting leaves.
The
liverwort Herbertus aduncus can exercise antifungal activity
against this fungus, but activity is age-dependent. Photo by
Howard F. Schwartz, through Creative Commons.

Figure 70. Herbertus aduncus, a leafy liverwort that can
exercise antifungal activity against several fungi, but activity is
age-dependent. Photo by Martin Hutten, with permission.

Figure 67. Botrytis cinerea on grapes. The liverwort
Herbertus aduncus can exercise antifungal activity against this
fungus, but activity is age-dependent. Photo by Alexandre
Dulaunoy, through Creative Commons.

Vashistha et al. (2007) determined the antimicrobial
activity for the thallose liverworts Plagiochasma
appendiculatum (Figure 48), Marchantia polymorpha
(Figure 47), and Conocephalum conicum (Figure 10).
Acetone-soluble extracts of all three bryophyte species
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were inhibitory against the fungal pathogens tested.
Plagiochasma appendiculatum had a strong inhibitory
effect against Aspergillus. niger and C. conicum was
strongly inhibitory to Candida albicans. When Niu et al.
(2006) tested Marchantia polymorpha (Figure 47) for
antifungal activities against the yeast Candida albicans
(Figure 46), they found plagiochin E, 13,13'-Oisoproylidenericcardin D, and neomarchantin A were active
against the yeast. The other identified compounds had only
weak effects.
Sabovljević et al. (2011) used DMSO extracts of both
cultured and wild grown mosses Atrichum undulatum
(Figure 20) and Physcomitrella patens (Figure 71-Figure
72) and thallose liverwort Marchantia polymorpha ssp.
ruderalis (Figure 47) to test for antifungal activity. Using
Aspergillus versicolor (Figure 73), Aspergillus fumigatus
(Figure 74), Penicillium funiculosum (see Figure 34),
Penicillium ochrochloron, and Trichoderma viride (Figure
66), these researchers demonstrated antifungal activity by
all three bryophytes against all five fungal species. Most of
the bryophytes grown in culture had greater antibiotic
activity than the wild-grown ones.

Figure 73. Aspergillus versicolor, a fungal species that is
inhibited by Atrichum undulatum, Physcomitrella patens, and
Marchantia polymorpha.
Photo by James Scott, through
Creative Commons.

Figure 71. Physcomitrella patens growing on agar plates.
Photo by Sabisteb, through Creative Commons.
Figure 74. Aspergillus fumigatus, a fungal species that is
inhibited by Atrichum undulatum, Physcomitrella patens, and
Marchantia polymorpha. Photo through Creative Commons.

Figure 72. Physcomitrella patens, a source of human
proteins and blood-clotting factor IX. Photo by Michael Lüth.

Alcoholic extracts of all twenty bryophytes tested at
Bonn University had antifungal activity on infected crops
(Frahm 2004), as demonstrated in a Petri dish (Figure 75).
Frahm reports curing a fungal infection of the skin with a
bryophyte extract. The success was reported in a TV
magazine and a published book, causing a number of
people to use the extract for fungal infections, mostly with
favorable results.
However, Frahm warns that the
biologically active substances are terpenoids, and these
may cause allergic effects to some people (Ando & Matsuo
1984). One reputedly can cure athlete's foot by walking
through a peat bog, presumably because of these same
terpenoids (Frahm 2004).

Chapter 2-2: Medical Uses: Biologically Active Substances

Figure 75. Bryophytes are known to inhibit growth of some
kinds of bacteria and fungi. Left: Microbes grow uninhibited
around a disk with only extraction fluid. Right: A zone of
inhibition occurs around the disk with bryophyte extract. Photo
by Jan-Peter Frahm.

One extract has actually been patented to cure fungal
infections of horses (Frahm 2004). An industrious horse
owner was inspired by what he read about the Bonn
experiments and made a paste of Ceratodon purpureus
(Figure 76) and Bryum argenteum (Figure 77). The
fungus disappeared from the horse in 24 hours! This same
extract is also sold as a human foot cream to refresh and
fight odor. Unfortunately, the use for curing fungal
infections cannot be mentioned in advertising because then
it would require the extensive testing necessary to meet
medical approval, which might be difficult because it can
cause allergies and dermatitis in some people. It also
works as an antifeedant against slugs. Unfortunately, to
date it must be extracted from field-collected material,
creating conservation concerns.
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Figure 77. Bryum argenteum, a species that was used in a
paste with Ceratodon purpureus and killed a fungal infection on
a horse. Photo by Martin Hutten, with permission.

Figure 78.
Chaetomium globosum.
The fungus
Chaetomium fusiforme occurs on Scapania verrucosa and
produces both antifungal and antitumor compounds. Photo by
Ulitca, through Creative Commons.

Antiviral Activity

Figure 76. Ceratodon purpureus, a species was used with
Bryum argenteum and killed a fungal infection on a horse. Photo
by Janice Glime.

It appears that some bryophytes may contribute to
antifungal compounds by hosting a fungus that
manufactures both antifungal and antitumor compounds
(Guo et al. 2008). The leafy liverwort Scapania verrucosa
hosts the fungus Chaetomium fusiforme (Figure 78). Not
only does the latter produce both antifungal and antitumor
compounds, but the liverwort itself likewise produces them.
However, the fungus compounds provide superior
properties and the liverwort might contribute to the
medicinal field through this fungal endophyte (organisms
growing within cells of plant, ranging from symbiotic to
parasitic).

Even viruses may some day be cured by extracts of
mosses, but we cannot simply identify them as "moss" as
many of our ecologist friends have been wanton to do in
reporting the ground cover. The Maoris of New Zealand
have used bryophytes to treat venereal disease by packing
wet plants on the infected organs (Frahm 2004).
Nevertheless, van Hoof and coworkers (1981) found no
effect of 20 species of moss extracts on the herpes virus,
but earlier Klöcking et al. (1976) found that at least some
peat humic acids possess antiviral activity against herpes
simplex virus types 1 and 2, interfering primarily with the
adsorption of viruses to host cells.
Sphagnum (Figure 13, Figure 14) produces several
antivirally active humic acids, and Camptothecium (Figure
79) extracts can inhibit growth of the poliovirus (Witthauer
et al. 1976; van Hoof et al. 1981). Nevertheless, actual
usage of bryophytic extracts has not developed outside of
Asia.
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Kumar et al. (2007) found that Indians have used
Polytrichum juniperinum (Figure 80) to treat cancer. The
anti-tumor use of bryophytes in India included
Chiloscyphus polyanthos (Figure 81), Diplophyllum
albicans
(Figure 82), D. taxifolium (Figure 85),
Marchantia palmata, and M. polymorpha (Figure 47).
Frullania tamarisci (Figure 43) is used as an antileukemic
agent. To this list, others added Riccardia sp. (Figure 84)
(Azuelo et al. 2011; Alam 2012; Chandra et al. 2017) and
Plagiochila sp. (Figure 11) (Asakawa 2007; Alam 2012;
Chandra et al. 2017).

Figure 79. Camptothecium lutescens, in a genus that can
inhibit growth of the poliovirus. Photo by David T. Holyoak,
with permission.

Cancer and Anti-tumor Properties
In the same year as the Madsen and Pates (1952) report
of antibiotics in bryophytes, Belkin et al. (1952-53)
reported anticancer activity against Sarcoma 37 in mice,
using extracts of Polytrichum juniperinum (Figure 80).
But application of the antitumor activity fared no better and
was apparently not rediscovered in bryophytes until the
next century. Finally, Anterola et al. (2009) considered the
anticancer drug precursors in mosses to be so important
that they titled their presentation on them "Turning
precursors into gold: Production of anticancer drug
precursors in moss."

Figure 80. Polytrichum juniperinum with antheridial splash
cups, a species that produces anticancer compounds. Photo by
Paul Slichter, with permission.

Fu et al. (2009) attempted to show anti-cancer
capabilities of the moss Polytrichum commune (Figure
19). To this end, they isolated two "unusual" flavones and
other compounds from this moss. However, when tested
against a small panel of cancer cell lines, they failed to find
any activity.

Figure 81. Chiloscyphus polyanthos, a species that may
cause allergic reactions.
Photo by Barry Stewart, with
permission.

Figure 82. Diplophyllum albicans, used as an anti-tumor
treatment in India and as an agent against epidermoid carcinoma.
Photo by Michael Lüth, with permission.

Asakawa (1981) has shown that several compounds
from leafy liverworts exhibit antileukemic activity. From
the thallose species, Marchantin A from Marchantia
palacea (Figure 83), M. polymorpha (Figure 47), and M.
emarginata subsp. tosana (Figure 33), riccardin from
Riccardia multifida (Figure 84), and perrottetin E from
Radula perrottetii all show cytotoxicity against the
leukemic KB cells (Asakawa et al. 1982).
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Hughes and Anterola (2010) attempted to transplant
genes for producing Taxol (a potent anticancer agent) into
the moss Physcomitrella patens (Figure 71, Figure 72).
They found evidence of small amounts of the anticancer
precursors in the moss. If the moss can be taught
(genetically) to produce Taxol, it could become a
laboratory means to manufacture this important anti-cancer
drug without destroying the diminishing number of Taxus
(Figure 86) shrubs that produce it naturally. Bryophytes
are ideal organisms for such gene transplants because of
their dominant state with a single set of chromosomes and
the relative ease with which genes can be put into them.

Figure 83. Marchantia paleacea, a thallose liverwort known
for its antileukemic activity. Photo by Jan-Peter Frahm, with
permission.

Figure 86. Taxus baccata, member of the genus that
produces the anticancer agent Taxol. Photo through Creative
Commons.

In 1976, Adamek reported that peat preparations hold
some promise against some types of human cancer. In
1977, Ohta and coworkers (1977) reported that
diplophyllin, isolated from the liverworts Diplophyllum
albicans (Figure 82) and D. taxifolium (Figure 85), shows
significant activity (ED50 4-16 µg/ml) against human
epidermoid carcinoma (KB cell culture).

When Asakawa (1981, 1982) entered the arena, he
isolated the sesquiterpenoids costunolide and tulipinolide
from Conocephalum supradecompositum, Frullania
monocera, F. tamarisci (Figure 43), Marchantia
polymorpha (Figure 47), Wiesnerella denudata (Figure 87)
and Porella japonica (Figure 88). To this list, Matsuo and
coworkers (1980, 1981a, b, c, 1984) added Lepidozia vitrea
(Figure 89) and Plagiochila semidecurrens (Figure 90).
These substances, already known from higher plants, have
activity to combat carcinoma of the nasopharynx, at least in
cell culture.

Figure 85. Diplophyllum taxifolium, a species that produces
diplophyllin, a compound that is active against human epidermoid
carcinoma. Photo by Hermann Schachner, through Creative
Commons.

Figure 87. Wiesnerella denudata, a species that produces
sesquiterpenoids that are likely to have antibiotic properties.
Photo by Ying Jia-dong, through Creative Commons.

Figure 84. Riccardia multifida, a thallose liverwort known
for its antileukemic activity. Photo by Michael Lüth, with
permission.
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Figure 90. Plagiochila semidecurrens, a species that
produces compounds that combat carcinoma of the nasopharynx.
Photo by Martin Hutten, with permission.

Figure 88. Porella japonica, a species that produces
compounds that combat carcinoma of the nasopharynx. Photo
from Taiwan mosses color illustrations, through Creative
Commons.

Figure 89. Lepidozia vitrea, a species that produces
compounds that combat carcinoma of the nasopharynx. Photo by
Lin Shanxiong, through Creative Commons.

When the National Cancer Institute became interested,
Spjut and his coworkers (1986) tested 184 species of
mosses and 23 species of liverworts for antitumor activity.
Of these, 43 species contained active substances, while
those of 75 species were toxic to tested mice. The most
activity was found in Brachytheciaceae (Figure 91),
Dicranaceae (Figure 16), Grimmiaceae (Figure 92),
Hypnaceae (Figure 61), Mniaceae (Figure 18, Figure 31),
Neckeraceae (Figure 2), Polytrichaceae (Figure 19,
Figure 80), and Thuidiaceae (Figure 93). However, in
1988, doubt was cast on the role of the moss when this
team reported that the antitumor activity of the moss
Claopodium crispifolium (Figure 94) was greatest in
samples contaminated with the Cyanobacterium Nostoc cf.
microscopicum (Figure 95), suggesting that Nostoc could
be the direct source of the activity or a necessary partner
for interaction between the species (Spjut et al. 1988).
Interaction could result from the transfer of a precursor
from the Nostoc to the moss, which could then transform it
into an active substance. Alternatively, the moss might
produce the substance as an allelopathic response to the
Nostoc. In any event, this raises important and intriguing
questions, both medically and ecologically.

Figure 91. Brachythecium salebrosum (Brachytheciaceae).
Some members of this family exhibit high antitumor activity.
Photo by Hermann Schachner, through Creative Commons.
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Figure 92. Grimmia nutans (Grimmiaceae).
Some
members of this family exhibit high antitumor activity. Photo by
Michael Lüth, with permission.
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Figure 95. Nostoc sp., a moss contaminant that can increase
anti-tumor activity.
Photo from Retina, through Creative
Commons.

For some reason, much of the biochemical work has
concentrated on the liverworts. Similar studies on activities
of moss compounds are sparse and there may be good
reason to presume a greater medical treasure chest among
the liverworts. Since these compounds generally benefit
the bryophytes by discouraging their would-be herbivores,
it is the tiny, slow-growing liverworts that stand to benefit
most.
Where other, larger plants have spent their
evolutionary history developing a diversity of structure, it
would seem that small size has afforded these plants only
the benefits of diversity of biochemistry as a means of
combating the hungry herbivores.
Burgess et al. (2000) found that the leafy liverwort
Bazzania novae-zelandiae (Figure 96) produces a
sesquiterpene caffeate that has selective activity against
certain human tumor cells. The active compound has been
identified as the new compound naviculyl caffeate.
Figure 93. Thuidium tamariscinum (Thuidiaceae). Some
members of this family exhibit high antitumor activity. Photo by
Malcolm Storey (DiscoverLife.com), with online permission.

Figure 96. Bazzania novae-zealandiae, a species that is
active against human tumor cells. Photo by Shirley Kerr, with
permission.
Figure 94. Claopodium crispifolium, a moss that provides
habitat for Nostoc, which in turn has anti-tumor properties. Photo
from Botany Website, UBC, with permission.

Even breast cancer sufferers might benefit from
bryophytes. Huang et al. (2010) found that marchantin A
produced by Marchantia emarginata subsp. tosana
(Figure 33) induced apoptosis in MCF-7 breast cancer
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cells. This compound demonstrates strong antioxidant
activity, scavenging free radicals.
The leafy liverwort Scapania verrucosa and its
endophytic fungal inhabitant Chaetomium fusiforme (see
Figure 78) produce several compounds that act as
antitumor agents (Guo et al. 2008).
The thallose liverwort Dumortiera hirsuta (Figure 15)
produces riccardin D, a macrocyclic bisbibenzyl
compound that induces apoptosis of human leukemia cells
(Xue et al. 2012). Xue and coworkers verified anticancer
activity by riccardin D against human non-small cell lung
cancer. In mice it produced a 44.5% inhibition of cancer
growth with no apparent toxicity.

complex moss system, compared to bacteria and fungi,
permits a much wider array of expression than is possible
in those systems. Thus, mosses are extremely useful as
production systems for targeted substances that can be
produced through gene manipulation.

Pharmaceutical Production
Welcome to Greenovation! Moss for a healthy future.
So began the website <http://www.greenovation.com/> of
an upstart company that is growing the tiny Physcomitrella
patens (Figure 71, Figure 72) for medicinal purposes. Yes,
bryophytes have indeed finally penetrated the forefront of
modern medicine!
Physcomitrella patens (Figure 71, Figure 72) is able to
accept transferred human genes and express them to
produce human antibodies in a liquid culture, making the
antibodies easy to harvest (ETH Zurich 2009). So far, this
is not possible when the genes are transplanted into "higher'
organisms. One advantage of Physcomitrella patens is its
ability to grow in a "bioreactor" (Figure 97; Decker &
Reski 2004), a fermenter in which only water and minerals
are needed to nourish the moss, of course in the presence of
light and CO2 (Greenovation). These tiny plants are
actually superior (and cheaper) production systems for
many complex recombinant pharmaceuticals (Bauer et al.
2005; Decker & Reski 2007, 2012; Gitzinger et al. 2009).
Contrary to many mammalian systems that have been used
to produce pharmaceuticals but that cause serious immune
responses, those produced by Physcomitrella patens are
non-immunogenic, a huge advantage for the patient, and
making them superior to currently used mammalian cell
lines for producing antibodies.
Among its many assets, Physcomitrella patens (Figure
71, Figure 72) is able to produce human proteins (Hohe et
al. 2002; Decker et al. 2003) and is the only plant being
used to produce the blood-clotting factor IX for
pharmaceutical use. This discovery, patented by Prof.
Reski of the Institute of Biotechnology of Plants at the
University of Freiburg in Germany, led to the founding of
the Greenovation Company in 1999. By 2002, the
company was already employing 30 people to produce this
valuable blood factor (Frahm, Bryonet discussion 2002).
Bryophytes offer the researchers, and the company, a
number of advantages over "higher" plants. They can be
grown without antibiotics, hence avoiding the danger of
contamination of the final product. The moss is quite small
and thus is cultured only in the lab with little danger of the
transgenic plants escaping into the environment. But the
real advantage comes from the dominant gametophytic
generation of mosses as opposed to the dominant
sporophyte of the tracheophytes. As a result, mosses are
the only plants known to have a high frequency of
homologous recombination. The result – stable integration
of inserted genes into the genome. Furthermore, the highly

Figure 97. This type of bioreactor is used to grow
Physcomitrella patens for human proteins and human bloodclotting factor IX. Photo by Ralf Reski.

Unfortunately, most biologically active substances so
far obtained have not proved economical for use, at least in
part due to the slow-growing nature and difficulty of
culturing bryophytes. And, while their pharmaceutical use
seems promising, we lack any understanding of their
potential harmful side effects.
In the words of Ma et al. (2003), "Imagine a world in
which any protein, either naturally occurring or designed
by man, could be produced safely, inexpensively and in
almost unlimited quantities using only simple nutrients,
water and sunlight. This could one day become reality as
we learn to harness the power of plants for the production
of recombinant proteins on an agricultural scale. Molecular
farming in plants has already proven to be a successful way
of producing a range of technical proteins. The first plantderived recombinant pharmaceutical proteins are now
approaching commercial approval, and many more are
expected to follow."
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Medical Dangers
Caution is in order in exercising any medicinal use of
bryophytes, particularly liverworts, because of their
potential for causing allergic reactions (Mitchell et al.
1969, 1970; Benezra et al. 1985, Asakawa 2012). Often
the very compounds that have these medical potentials can
cause allergic reactions. For example, it is a sesquiterpene
lactone (Asakawa 1981) that gives the common epiphyte
Frullania (Figure 98-Figure 99) its ability to cause contact
dermatitis, especially to forest workers (Mitchell et al.
1969). Now there is a patch test with a sesquiterpene
lactone mix to determine sensitivity to Frullania (Quirce et
al. 1994).
Yet sesquiterpene lactones are well known for their
antimicrobial activity. In southern Europe, Frullania
tamarisci (Figure 43, Figure 98) imparts an allergic
reaction to olive pickers, yet is listed as one of the
medicinal species (J. Curnow, pers. comm.). D. H. Wagner
(pers. comm.) reports an allergy to Chiloscyphus
polyanthos (Figure 81), especially when he squeezes it to
remove excess water. By 1981, 24 liverwort species were
known to have potential allergenic sesquiterpene lactones
(Asakawa 1981). These compounds undoubtedly endow
the same advantage to bryophytes that they do to flowering
plants – discouraging consumption by hungry herbivores.

Figure 99. Frullania nisquallensis, a leafy liverwort
epiphyte that causes allergic reactions among forest workers.
Photo by Dale Vitt, with permission.

Figure 100. Thuja plicata, host plant for Frullania species.
Photo from <www.nwplants.com>, through Creative Commons.

Summary

Figure 98. Frullania tamarisci, showing underside of
branch with lobules by which the genus may be determined.
Photo by Michael Lüth, with permission.

Frullania tamarisci (Figure 43, Figure 98) grows on
trees and can cause skin irritations for loggers and even for
their wives who handle their clothes. Allergic reactions to
Frullania nisquallensis (Figure 99) occurred in patch tests
on seven forest workers who had contact dermatitis
(Mitchell et al. 1969). These forest workers exhibited the
dermatitis only when they were working on forest areas.
The problem was worse in wet weather and appeared
within 1-2 days of starting work. The condition persisted
for 2-4 weeks after leaving work in forested areas where
the liverwort grew. The condition is often known locally in
British Columbia, Canada, as cedar poisoning, but in fact it
is caused by the liverworts that commonly grow on the
cedars (Thuja; Figure 100).

Bryophytes, especially liverworts, often have
distinct odors, suggesting aromatic compounds such as
phenols. However, few bryophytes have been linked to
actual curative properties and identifiable associated
compounds.
One danger in using bryophytes is that the same
compounds that may have antibiotic properties may
also be toxic or allergenic, or be associated with such
compounds. Furthermore, peatland mosses may have
associated fungi that cause sporotrichosis.
Many antibiotics have been isolated from
bryophytes, but few have been developed for medical
use, despite their demonstrated effectiveness.
In
Germany, Ceratodon purpureus and Bryum
argenteum are used to cure fungal infections of horses.
Several medical uses seem promising, such as
antileukemic properties and anticancer agents.
The most promising uses of bryophytes in
medicine seem to lie in genetic engineering.
Bryophytes are being used already to produce human
blood-clotting proteins, while others are known to
reduce thrombin activity.
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